Karen S Gustafson, MD, PhD

faculty photo
Associate Professor of Clinical Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine

Contact information
University of Pennsylvania Medical Center
6 Founders, Room FO6.042
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-662-3209
Education:
B.A. (Biology and Chemistry)
Gustavus Adolphus College, 1983.
MD, PhD (Biomedical Science)
University of Minnesota Medical Scientist Training Program, 1998.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Vijayvergia, N., Boland, P. M., Handorf, E., Gustafson, K. S., Gong, Y., Cooper, H. S., Sheriff, F., Astsaturov, I. A., Cohen, S. J., Engstrom, P. F. : Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: A Fox Chase Cancer Center pilot study. Br. J. Cancer. 115(5): 564-570, August 2016.

Farma, J., Kulkarni, N., Escalante, D.A., Meade, C., Osevala, N., Zibelman, M., Gustafson, K.S., Wu, H., Lango, M., Reddy, S., Movva, S., Olszanski, A.J., Zih, F.S.: Molecular profiling and clinical outcomes in patients with in-transit recurrence of melanoma. Ann. Surg. Oncol. 23, 2016.

Vijayvergia, N., Cohen, S.J., Boland, P.M., Gustafson, K.S., Sherrif, F., Cooper, H., Astaturov, I., Engstrom, P.F.: Molecular profiling defines subsets of neuroendocrine tumors (NETs) with aggressive disease: A Fox Chase Cancer Center (FCCC) study. Pancreas 45(3): 469-470, 2016.

Kaczmar, J.M., Gustafson, K.S., Wong, Y.N., Minniti, C.J., Sandilya, V.K., Sprandio, J.D., Chertock, Y., Hart, C., Hall, M.J.: Tumor genomic profiling (TGP) in metastatic colorectal cancer (CRC): Bridging the community and the tertiary cancer center through genomic consultation (GC). J. of Clin. Oncol. 34(4), 2016.

Zih, F.S., Kulkarni, N., Escalante, D.A., Meade, C., Osevala, N., Zibelman, M., Movva, S., Gustafson, K.S., Wu, H., Reddy, S., Lango, M., Olszanski, A.J., Farma, J.: Molecular profiling and clinical outcomes in malignant melanoma: Experience at a NCI-designated cancer center. Ann. Surg. Oncol. 23, 2016.

Shih J, Bashir B, Gustafson KS, Andrake MA, Dunbrack RL, Goldstein LJ, Boumber Y. : CSI: Cancer Signature Investigation: ERBB2 (HER2)-activating mutation and amplification-positive breast carcinoma mimicking lung primary. J. Natl. Compr. Canc. Netw 2015.

Vijayvergia, N., Boland, P. M., Cohen, S. J., Gustafson, K. S., Cooper, H. S., Astsaturov, I. A., Engstrom, P. F. : Molecular profiling of neuroendocrine tumors (NETs): The Fox Chase Cancer Center (FCCC) experience. J. of Clin. Oncol. 33(3), 2015.

Zibelman, M. R., Kulkarni, N., Lango, M., von Mehren, M., Movva, S., Gustafson, K. S., Reddy, S. S., Wu, H., Farma, J. M., Olszanski, A. J. : Molecular markers in malignant melanoma: Experience at an NCI-designated cancer center. J. of Clin. Oncol. 33(15), 2015.

Matthew, E.M., Zhou, L.L., Vijayvergia, N., Dicker, D.T., Gustafson, K.S., Cooper, H.S., Ross, E.A., Lim, B., Harouaka, R., Zheng, S.Y., Lamparella, N.E., Drabick, J.J., Truica, C.I., Yang, Z.H., El-Deiry, W.S. : A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells. Cancer Res. 75, 2015.

Vijayvergia, N., Boland, P. M., Gustafson, K. S., Sheriff, F., Cooper, H. S., Cohen, S. J., Astsaturov, I. A., Engstrom, P. F.: Molecular profiling of advanced stage neuro endocrine tumors (NETs): The Fox Chase Cancer Center (FCCC) experience. Pancreas 44(2), 2015.

back to top
Last updated: 11/14/2017
The Trustees of the University of Pennsylvania